Beverly, MA, United States of America

Diana O'Loane


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Diana O'Loane: A Pioneer in Molecular Biology

Introduction

Diana O'Loane, based in Beverly, MA, is a notable inventor renowned for her contributions to the field of molecular biology. Her innovative work primarily focuses on recombinant DNA technology, which has significant implications for genetic research and biotechnological applications.

Latest Patents

Diana holds a patent for the "Method for cloning and expression of AcuI restriction endonuclease and AcuI methylase in E. coli." This invention relates to recombinant DNA encoding the AcuI restriction endonuclease and AcuI methylase, which allows for the expression of these enzymes in cells containing the recombinant DNA. This advancement is crucial for researchers working with genetic material, offering tools for precise DNA manipulation.

Career Highlights

Currently, Diana is associated with New England Biolabs, Inc., a leading company in the life sciences sector that specializes in the production of reagents for DNA research. Throughout her career, she has demonstrated exceptional expertise in molecular cloning and enzyme expression, establishing herself as a valuable contributor to biotechnological advancements.

Collaborations

Diana collaborates with fellow researchers, including James C Samuelson and Shuang-Yong Xu. Their joint efforts in the laboratory foster an environment of innovation and further enhance the capabilities of recombinant DNA technology in various applications.

Conclusion

Diana O'Loane's contributions to molecular biology, particularly through her patented work on the AcuI restriction endonuclease and methylase, cement her status as an influential inventor in the biotechnology industry. Her affiliation with New England Biolabs, Inc. and collaboration with esteemed colleagues highlight her commitment to advancing scientific knowledge.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…